<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many cytotoxic agents kill cells by invoking a specific <z:hpo ids='HP_0011420'>death</z:hpo> pathway termed physiological cell <z:hpo ids='HP_0011420'>death</z:hpo>, or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Treatment of a murine hemopoietic stem cell line, FDCP-mix, with <z:chebi fb="0" ids="25255">methylmethanesulfonate</z:chebi> (<z:chebi fb="1" ids="25255">MMS</z:chebi>) or N'-<z:chebi fb="36" ids="29309">methyl</z:chebi>-N'-nitrosourea (MNU) leads to <z:hpo ids='HP_0011420'>death</z:hpo> by <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Retroviral gene transfer was used to overexpress the bcl-2 oncogene in FDCP-mix cells, and this was associated with a delay in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in these cells after treatment with MNU and <z:chebi fb="1" ids="25255">MMS</z:chebi> and decreased sensitivity of colony formation to the cytotoxic effects of <z:chebi fb="1" ids="25255">MMS</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>These data suggest an explanation for the refractory nature of bcl-2-expressing follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to cytotoxic chemotherapy and furthermore suggest that DNA-damaging antitumor therapy may contribute to the progression of disease </plain></SENT>
</text></document>